Polar Asset Management Partners’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Polar Asset Management Partners’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-540,499	Closed	-$5.56M	–	1245
2022 Q4	$5.56M	Buy	540,499 +99	+0%	+$1.01K	0.07%	396
2022 Q3	$5.44M	Buy	540,400 +40,400	+8%	+$406K	0.07%	451
2022 Q2	$5.01M	Hold	500,000	–	–	0.06%	467
2022 Q1	$5M	Hold	500,000	–	–	0.05%	423
2021 Q4	$4.95M	Buy	+500,000	New	+$4.94M	0.05%	409

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Polar Asset Management Partners's IQMD Position: Q1 2023 in Review

Polar Asset Management Partners sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 540,499 shares — an estimated $5.56M sold.

Polar Asset Management Partners first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $5.56M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Polar Asset Management Partners reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Polar Asset Management Partners sold 540,499 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $5.56M.
Polar Asset Management Partners first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Polar Asset Management Partners's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $5.56M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.